Nektar Therapeutics reported $-145649000 in Pre-Tax Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -98.58M 14.32M
Bluebird Bio BLUE:US $ -132.24M 84.69M
Dr.Reddys Laboratories DRRD:IN IR 9709M 3016M
Eisai 4523:JP Y 13890M 8326M
Immunogen IMGN:US $ -24.14M 13.03M
IONIS PHARMACEUT IONS:US $ 225M 309M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Nektar Therapeutics NKTR:US $ -145.65M 16.06M
Novartis NOVN:VX SF 3682M 862M
Teva Pharmaceutical TEVA:IT -175000000 557M